Medical Professionals Clarify the Role of Zulresso in Treating Postpartum Depression and the Importance of Diagnostic Precision
The landscape of maternal mental health underwent a significant shift in March 2019 following the U.S. Food and Drug Administration’s approval of Zulresso (brexanolone), the first medication specifically indicated for…
